Optinose (NASDAQ: OPTN) has announced plans to release its financial results for the fourth quarter and full year of 2024, ...

Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We really hate to ...

Company to Host Conference Call Members of the Company’s leadership team will host a conference call to discuss financial results and corporate updates. The call is scheduled to start at 8:00 a.m.

EST OptiNose (OPTN) trading halted, volatility trading pauseDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

Jan. 15, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced preliminary ...

Jan. 15, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced preliminary ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Optinose Inc is listed on the CBOE trading with ticker code OPTN.US. It has a market capitalisation of $58.42m, with approximately 10.06m shares in issue. Over the last year, Optinose Inc share ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...